Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    cerebral palsy | United States, Washington
Show Display Options
Rank Status Study
1 Completed
Has Results
Orthotics in Ambulatory Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Device: SAFO worn;   Other: SAFO not worn
2 Completed Botulinum Toxin (BOTOX) for Cerebral Palsy
Conditions: Cerebral Palsy;   Muscle Spasticity
Intervention: Drug: Botulinum toxin type A
3 Completed Activity and Participation in Ambulatory Cerebral Palsy
Condition: Cerebral Palsy
Intervention:
4 Recruiting Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Other: home-based treadmill training;   Device: Treadmill
5 Unknown  Relaxation Training to Decrease Pain and Improve Function in Adolescents With Cerebral Palsy
Condition: Cerebral Palsy
Intervention: Behavioral: biofeedback-monitored relaxation training
6 Active, not recruiting On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Condition: Cerebral Palsy
Intervention:
7 Completed
Has Results
Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Condition: Cerebral Palsy (CP)
Interventions: Drug: dalfampridine-ER 10mg;   Other: Placebo
8 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
9 Recruiting BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention: Biological: botulinum toxin Type A
10 Recruiting BOTOX® Treatment in Pediatric Lower Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
11 Not yet recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: erythropoietin
12 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
13 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
14 Recruiting Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults
Condition: Sialorrhea
Intervention: Drug: MYOBLOC
15 Completed
Has Results
Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: 10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP);   Drug: 15 mg fampridine-SR (4-aminopyridine, 4-AP);   Drug: 20 mg fampridine-SR (4-aminopyridine, 4-AP)
16 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

Study has passed its completion date and status has not been verified in more than two years.